|Articles|October 2, 2020
- Pharm Exec E-Books-10-01-2020
- Volume Sponsored eBook
- Issue 1
The Changing Landscape of Biopharma Finance
In today’s fast-paced marketplace and complicated regulatory environment, operating in the life sciences industry can bring a variety of challenges. From raising capital or addressing pricing pressures to prioritizing development efforts or managing third-party risks, the landscape of Biopharma Finance is changing.
Related Content
Trending on PharmExec
1
Study Shows Link Between Zepbound and Lower Healthcare Costs in Adults Aged 55 and Up with Obesity: Report
2
FDA Approves Daraxonrasib as First-in-Class Targeted Therapy for Metastatic Pancreatic Cancer
3
The Retailization of Medicare Advantage: What Costco’s Entry Means for Pharma
4
M&A Roundup: McKesson to Acquire Precision Medicine Group, Lundbeck & Eversana Enter AI-Powered Partnership
5